What type of acute kidney injury is associated with amphetamine abuse?

Amphetamine-Associated Acute Kidney Injury: Mechanisms and Clinical Patterns

Amphetamine abuse is primarily associated with acute tubular necrosis (ATN) secondary to rhabdomyolysis with myoglobinuria, though acute interstitial nephritis (AIN) and thrombotic microangiopathy (TMA) can also occur. 1, 2, 3

Primary Mechanism: Rhabdomyolysis-Induced ATN

The most common pathway to AKI in amphetamine abuse involves rhabdomyolysis leading to myoglobinuric acute renal failure 2, 4:

• Amphetamines cause severe muscle breakdown through multiple mechanisms including hyperpyrexia, seizures, agitation, and direct muscle toxicity 1, 2
• Myoglobin released from damaged muscle causes tubular obstruction with myoglobin casts and direct tubular toxicity 2
• The FDA label explicitly warns that rhabdomyolysis is a manifestation of acute amphetamine overdosage, and acidification of urine (previously used to enhance amphetamine excretion) increases the risk of acute renal failure when myoglobinuria is present 1

Clinical Recognition of Rhabdomyolysis-ATN:

• Dark or reddish urine without apparent explanation 1
• Markedly elevated serum creatine kinase (can reach >83,000 ng/mL) 2, 4
• Urine myoglobin levels dramatically elevated (>400,000 ng/mL reported) 2
• Associated with hyperpyrexia, extreme dehydration, and electrolyte disturbances 4
• Renal biopsy shows tubular degeneration and tubular obstruction with myoglobin casts on immunofluorescence 2

Alternative Mechanisms of Amphetamine-Induced AKI

Acute Interstitial Nephritis (AIN)

Amphetamine alone can cause acute interstitial nephritis independent of rhabdomyolysis or other complications 5:

• This represents a type B (idiosyncratic, unpredictable) drug reaction 6
• Renal biopsy demonstrates acute interstitial nephritis without evidence of rhabdomyolysis, hyperpyrexia, or necrotizing angiitis 5
• This mechanism is less common but clinically important as it represents direct drug-induced kidney injury 5

Thrombotic Microangiopathy (TMA)

Methamphetamine can induce renal TMA with multi-organ involvement 3:

• Renal biopsy reveals fibrin thrombi within glomerular capillaries and fibrotic intimal thickening in interlobular arteries 3
• Associated with severe hypertension, thrombocytopenia, elevated lactate dehydrogenase, and heart failure 3
• Blood concentrations of amphetamine (14.1 ng/mL) and methamphetamine (333 ng/mL) confirm exposure 3
• Can cause cardiomyopathy and coronary artery stenosis as part of multi-organ dysfunction 3

Necrotizing Angiitis

Chronic intravenous amphetamine use can cause vasculitis leading to progressive renal failure 7:

• Amphetamine-induced angiitis is a distinct clinical entity that can be potentially lethal 7
• Disease may exacerbate with continued amphetamine usage 7
• Can progress over years to terminal renal failure 7
• Represents vascular injury rather than tubular or interstitial pathology 7

Hemodynamic and Functional Mechanisms

Amphetamines cause AKI through both structural damage and hemodynamic dysfunction 8:

• Acute severe blood pressure elevations reduce renal perfusion pressure, and if sustained or severe, lead to ischemic injury 9
• Systemic hypotension from systemic arterial vasodilation can occur 8
• Altered intraglomerular hemodynamics through effects on afferent and efferent arterioles 8
• Endothelial dysfunction contributes to both functional and structural kidney injury 9

Clinical Framework for Classification

Drug-induced AKI from amphetamines involves both functional and structural components 8:

• Functional AKI: Hemodynamic effects from severe hypertension or hypotension 8
• Structural AKI: Direct tubular injury from myoglobin, interstitial inflammation, or vascular damage 8
• Combined functional/structural AKI: Most common presentation where hemodynamic instability leads to or compounds structural damage 8

Risk Factors and Complications

Multiple factors compound the risk and severity of amphetamine-associated AKI 4, 10:

• Extreme dehydration and electrolyte disturbances worsen rhabdomyolysis 4
• Disseminated intravascular coagulation (DIC) can complicate severe cases 4
• Polydrug use (MDMA, THC combined with amphetamines) increases complications 4, 10
• Malignant hypertension and electrolyte disturbances with MDMA/ecstasy 10

Management Priorities

Treatment focuses on supportive care and preventing progression 1:

• Avoid urine acidification despite historical use for amphetamine excretion, as it increases risk of acute renal failure with myoglobinuria 1
• Adequate hydration, forced diuresis, and urine alkalinization are cornerstones when myoglobinuria is present 11
• Monitor serum creatine kinase and potassium closely to prevent myoglobinuric renal failure and dysrhythmias 11
• Discontinue nephrotoxic agents and ensure volume status and perfusion pressure 12
• Dialysis treatment started early improves outcomes in severe cases 4
• Referral to appropriate therapeutic programs is reasonable for patients who abuse amphetamines given stroke and renal risks 9